Claro Advisors LLC lessened its stake in The Clorox Company (NYSE:CLX – Free Report) by 19.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,321 shares of the company’s stock after selling 1,278 shares during the period. Claro Advisors LLC’s holdings in Clorox were worth $864,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. Prospera Private Wealth LLC acquired a new position in Clorox in the 3rd quarter valued at about $27,000. Continuum Advisory LLC increased its position in Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after acquiring an additional 138 shares during the period. Quarry LP increased its position in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after acquiring an additional 114 shares during the period. Carolina Wealth Advisors LLC acquired a new position in Clorox in the 3rd quarter valued at about $48,000. Finally, Friedenthal Financial acquired a new position in Clorox in the 3rd quarter valued at about $49,000. Institutional investors and hedge funds own 78.53% of the company’s stock.
Analyst Ratings Changes
CLX has been the topic of several recent research reports. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and boosted their price target for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Barclays boosted their target price on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research report on Friday, November 1st. JPMorgan Chase & Co. boosted their target price on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Finally, Evercore ISI dropped their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $157.46.
Clorox Price Performance
CLX stock opened at $157.32 on Tuesday. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The stock’s 50 day moving average price is $164.55 and its 200 day moving average price is $156.00. The firm has a market cap of $19.47 billion, a P/E ratio of 54.82, a PEG ratio of 3.04 and a beta of 0.42.
Clorox (NYSE:CLX – Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the prior year, the company earned $0.49 EPS. Clorox’s revenue was up 27.0% on a year-over-year basis. On average, sell-side analysts expect that The Clorox Company will post 6.85 earnings per share for the current fiscal year.
Clorox Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.10%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio is presently 170.03%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- Basic Materials Stocks Investing
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- The Significance of Brokerage Rankings in Stock Selection
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- What Are Dividend Champions? How to Invest in the Champions
- Delta Can Fly to New Highs in 2025; Here’s Why
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.